LOCUST WALK WEBINARS & PANELS
On the heels of the publication of Locust Walk’s white paper “Crossover Evolution: The Evolving Role of the Crossover Financing Round” join us for a live webinar discussion.
The Covid-19 pandemic was the biggest biopharma news of 2020. It may be hard to remember now, but in March of last year, biotech indices had quickly nose-dived. That was temporary. Biotech had a record-setting performance for the remainder of the year, when it led the bull market to record highs and unprecedented fundraising. Crossover financing rounds were a leading trend in that recovery.
Each quarter our team at Locust Walk compiles key statistics and trends on strategic transactions and financings. Our 2021 Q1 Report: Global Trends in Biopharma Transactions applies the latest data to analyze current activities in the life science deal landscape. For this quarter’s webinar, we’ll be discussing the nuances of early-stage collaborations relative to recent dealflow.
Considering the financing landscape for biopharma companies continues to be robust, a big question remains, which is ‘how long can we trust this trend?’ While predicting the future isn’t realistic, we brought together a handful of panelists to discuss current biopharma financing trends and share things to consider while you’re mapping out your strategy for 2021 and beyond.
Though there’s no shortage of female-led biotech companies, women still make up less than 20% of biotech boards. Often times women are asked “have you been on a board before?” But how do women get that initial experience into the “club” when they continue to face roadblocks?
Please join Hayato Watanabe, SVP, Head of Asia at Locust Walk, Ken Araki, Corporate Officer, Head of Global Business Development at Santen Pharmaceutical Co., Ltd, Sean Cao, Managing Director, CBC Group, and Wendy Pan, Partner, Technology & Life Sciences Group, Goodwin.
Accessing Capital in the time of COVID: Challenges, Opportunities, and Best Practices – June 11, 2020
Join Brian Coleman, Managing Director, Global Head of Capital Markets & Sales, Geoff Meyerson, CEO & Co-Founder of Locust Walk, Gregg Beloff, Managing Director of Danforth Advisors, and William Hicks, Partner at Mintz Levin to talk about how biopharma companies can get access to capital in this time. You don’t want to miss this one!
Join Geoff Meyerson, CEO & Co-Founder of Locust Walk, Chris Ehrlich, Senior Managing Director, Global Head of Strategic Partnerships at Locust Walk, Sara Solomon, Partner, Goodwin, and Malcolm Bates, Partner, Goodwin discuss strategies for maximizing strategic partnerships, especially in the time of COVID-19.
Join Geoff Meyerson, CEO & Co-Founder of Locust Walk, Chris Ehrlich, Senior Managing Director, Global Head of Strategic Partnerships at Locust Walk, and Barbara Cooley, Partner, International Head of Life Science Practice at Cooley to hear their insights on Q1 2020 biopharma trends and get an insight into what’s ahead for 2020.
Join Geoff Meyerson, CEO & Co-Founder of Locust Walk, Chris Ehrlich, Senior Managing Director, Global Head of Biopharma at Locust Walk, Brian Coleman, Managing Director, Global Head of Financing and Sales, along with Tim Ehrlich, Partner at Gunderson Dettmer to discuss the strategic implications COVID-19 is having on biopharma companies and investors.
Locust Walk has prepared this webinar in collaboration with T1D Exchange, a nonprofit whose mission is to accelerate new therapies and improve care for people affected by type 1 diabetes. This webinar is for anyone who is seeking to raise a private financing round.
This half an hour webinar will provide valuable education and insights into the best practices of life science deal-making based on Locust Walk’s transaction advisory experience.
The webinar will be a comprehensive overview of each section of a private financing term sheet. The content is geared towards life science senior executives and business development professionals who may be intimidated by and/or are interested in learning more about each of the sections of a term sheet and the purpose for its inclusion. Potential pitfalls of key terms will also be discussed.
Webinar provides valuable education and insights into the best practices of life science deal-making based on Locust Walk’s transaction advisory experience.
The session includes insights & techniques that will be interesting not only to potential buyers, but also to those on the sell-side looking to gain a greater understanding of the buy-side mentality.
Webinar covers key issues surrounding the fundamentals of and insights into how best to finance private biotechnology companies in today’s competitive and evolving marketplace. The session will also include an update on recent trends in the private financing market.
The webinar covers key issues surrounding how to best value a biopharma company. The content is geared towards life science senior executives and business development professionals who are interested in learning more about or improving their skills in valuation analysis.